AstraZeneca Pharma India Q4 profit falls 34%; board recommends Rs 16/share dividend

AstraZeneca Pharma India on Tuesday reported a net profit of Rs 17.3 crore for the quarter ended March 2023, marking a decline of 37.4 per cent compared with the corresponding period a year ago. Its revenue came in at Rs 284.7 crore as against Rs 222 crore for the year-ago period, according to a regulatory filing. 

AstraZeneca Pharma dividend

AstraZeneca Pharma India's board recommended a dividend of Rs 16 per equity share — an 800 per cent payout given the face value of Rs 2 per share.

AstraZeneca Pharma shares — traded on the bourses with the symbol ASTRAZEN — ended 2.4 per cent higher at Rs 3,332 apiece on BSE ahead of the earnings announcement.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.